A Phase Ib Study to Evaluate the Safety and Efficacy of Nivolumab in Combination with RCHOP in High-Risk DLBCL

Blood(2023)

Cited 0|Views14
No score
Abstract
Introduction
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined